Erythropoietin Drugs Market In-depth Insights, Revenue Details, Regional Analysis by 2028 | Intas Pharmaceuticals, LG Life Sciences Ltd., Roche

The erythropoietin drugs market was valued at $9,243.12 million in 2020, and is projected to reach $ 14,414.59 million by 2028, registering a CAGR of 5.7% from 2021 to 2028.

Erythropoietin is a glycoprotein hormone synthesized in the bone marrow that controls and regulates the mechanism of erythropoiesis (production of red blood cells). These erythropoietin (EPO) drugs are used for the treatment of chemotherapy-induced anemia. Improved recombinant DNA technology has led to the development of synthetic forms of erythropoietin such as epoetin-alfa, epoetin-beta, darbepoetin-alfa, epoetin-omega, and epoetin-delta.

The final report adds an analysis of the impact of COVID-19 on this industry: https://reportocean.com/industry-verticals/sample-request?report_id=AMR1801

The rise in the number of patients suffering from anemic conditions induced due to cancer, HIV, and ESRD treatment, favorable reimbursements, and an increase in the commercialization of EPO biosimilars are the major factors for the market growth. However, side effects such as arterial hypertension, iron deficiency, influenza-like syndrome, and a longer treatment period (4-6 weeks) hamper the growth of the erythropoietin drugs market. The availability of numerous biosimilars has rendered low-cost options for patients, therefore, increased adoption rates for EPO drugs particularly in developing regions, which boosts the market growth.

Furthermore, commercialization patterns for erythropoietin biosimilars, readily available reimbursements, favorable government regulations, and awareness regarding the benefits of EPO therapeutics contribute toward the growth of the erythropoietin drugs market.
The global erythropoietin drugs market is segmented into product type, application, and region.

On the basis of product type, the market is categorized into epoetin-alfa, epoetin-beta, darbepoetin alfa. By application, it is classified into anemia, kidney disorders, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Request discount link: https://reportocean.com/industry-verticals/ask-for-discount?report_id=AMR1801

KEY BENEFITS FOR STAKEHOLDERS

- The study provides an in-depth analysis of the global erythropoietin drugs market along with the current trends and future estimations to elucidate the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
- Comprehensive quantitative analysis of the industry from 2020 to 2028 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the key segments of the industry helps to understand the application and products of erythropoietin used across the globe.
- Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Type
- Epoetin-alfa
- Epoetin-beta
- Darbepoetin alfa

By Application
- Anemia
- Kidney Disorders
Others

By Region
- North America
o U.S.
o Canada
o Mexico
- Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
- Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
- LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT
- Amgen Inc.
- Biocon,
- Celltrion, Inc.
- Intas Pharmaceuticals
- Johnson & Johnson
- Hospira Inc.
- Intas Pharmaceuticals
- LG Life Sciences Ltd.
- Roche
- Ranbaxy Laboratories Ltd.
- Teva Pharmaceutical Industries Ltd.

Get our sample copy of the report: https://reportocean.com/industry-verticals/sample-request?report_id=AMR1801

Get in Touch with Us:
Report Ocean:
Email: sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 - UNITED STATES
Tel: +1 888 212 3539 (US - TOLL FREE)
Website: https://www.reportocean.com/

About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom line goals which will boost your market share in today's competitive environment. Report Ocean is a 'one-stop solution' for individuals, organizations, and industries that are looking for innovative market research reports.

This release was published on openPR.